Department Title Author Short Description Video Url
Pharmacy Dr. Ricardo San Martin: Using nano-emulsions to improve fat encapsulation The Good Food Institute Can nano-emulsions improve fat encapsulation in plant-based meat? Dr. Ricardo San Martin discusses novel approaches to replace saturated fats (e.g. coconut fat) used in the production of iconic plant-based meat products. Dr. San Martin presents preliminary results that show how nanoemulsions allow the use of more healthy oils in the formulation of plant-based meats. This solution reduces oil leakage during cooking, which is an undesirable trait of plant-based burgers. Meet the speaker: Dr. Ricardo San Martin is the Research Director of the Alternative Meat Program at the Sutardja Center for Entrepreneurship and Technology at UC Berkeley, where students explore entrepreneurial opportunities in alternatives to animal products (not just meat). This is a meaningful and complex challenge about which he cares deeply, especially since two of his four children are vegan. He holds a B.S. from Universidad Catolica de Chile in Chemical Engineering, an MSc. in Chemical Engineering from UC Berkeley and a Ph.D. in Biotechnology from Imperial College, London. For over 35 years, he has been a hands-on inventor and entrepreneur on plant-extracts, some of which are used by the companies developing vegan alternatives to meat. His company provides the natural foaming agent for US root beer. View
Pharmacy Basics Of Targeted Drug Delivery System You tube Basics Of Targeted Drug Delivery System View
Pharmacy New Approaches for Targeted Drug Delivery with Nanomedicines PrecisionNanoSystems New Approaches for Targeted Drug Delivery with Nanomedicines View
Pharmacy Targeted Delivering of Drugs in the Body: Drug Delivery Systems Kyoto University / 京都大学 Targeted Delivering of Drugs in the Body: Drug Delivery Systems View
Pharmacy Targeted delivery using aptamers Oligonucleotide Therapeutics Society Targeted delivery using aptamers View
Pharmacy Targeted Drug Delivery Systems (TDDS) in depth Pharmacy In Depth This video contains detailed information about various targeting approaches like- Passive targeting. Active targeting, Stimuli-responsive targeting, and its various types like pH, Temperature, Ultrasound, Magnetic, etc. View
Pharmacy Nanoparticle-based drug delivery in the fight against cancer Institute for Molecular Bioscience This animation describes the latest research developments in nanoparticle-based cancer therapies. It explores how the technology can be used to specifically target cancer cells over healthy cells and how scientists can exploit the natural processes of cells to deliver the drug inside the cell where it is needed for its cancer-killing effect. View
Pharmacy Taking control of sustained drug release – with Parteck® SRP 80 MilliporeSigma Pharma and Biopharma Manufacturing Patient convenience and compliance are major targets in pharmaceutical drug formulation, which is why solid oral formulations are some of the most well established dosage forms in the world. In many cases, long-acting efficacy of the API is required. The new Parteck® SRP 80 is a highly functional excipient that offers superior reliability and consistency in sustained release products. This video provides an overview of different release profiles, with a focus on sustained release, followed by technical information on how Parteck® SRP 80 enhances sustained release formulations including data on its dissolution performance. View
Pharmacy How to Perform IVIVC for Delayed Release Drug Formulations Certara In vitro-in vivo correlation (IVIVC) is a predictive mathematical tool that describes the relationship between an in vitro property of a drug dosage form and an in vivo pharmacokinetic response. Drug developers frequently use this approach to waive the requirement to show in vivo bioavailability or bioequivalence. In theory, developing an IVIVC is straightforward for immediate release oral formulations. Delayed release drug formulations deliver a drug with a delay after its administration. IVIVC then becomes a real challenge. This webinar showed how to use a time correction factor to establish a meaningful IVIVC for delayed release formulation drugs. View
Pharmacy Formulation and evaluation of sustained release matrix tablet, Part-II, experimental AdtU Formulation and evaluation of sustained release matrix tablet View